Key Details
Price
$278.41Last Dividend
$0.39Annual ROE
12.59%Beta
1.03Events Calendar
Next earnings date:
Feb 06, 2025Recent quarterly earnings:
Oct 16, 2024Recent annual earnings:
Feb 07, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Nov 22, 2024Next split:
N/ARecent split:
Dec 18, 1995Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
The company's stock rose more than 100% after promising results from a 96-week phase 2b SYMMETRY study that tested EFX for treating F4 compensated cirrhosis in MASH patients. The study showed a notable improvement in cirrhosis, with 39% of patients benefiting from EFX compared to only 15% in the placebo group, demonstrating the drug's effectiveness. Looking ahead, the company plans to conduct phase 3 SYNCHRONY studies for F1-F3 and F2-F3 MASH patients, with results anticipated in the first halves of 2026 and 2027, respectively.
ATLANTA, Jan. 22, 2025 /PRNewswire/ -- Equifax ® (NYSE: EFX) will share its financial results for the fourth quarter that ended on December 31, 2024. The announcement will be made in a press release on Thursday, February 6, at 6:30 a.m. Eastern Time (ET).
Equifax has reached a settlement and consent order to address claims made by the Consumer Financial Protection Bureau (CFPB). These claims stated that the credit reporting agency did not do enough to guarantee the accuracy of its credit reports.
Equifax's move to its own cloud and EFX.AI features is expected to increase revenue, improve profit margins, and generate more free cash flow, leading to higher profitability. With reduced capital expenditures and better margins, earnings per share (EPS) are projected to rise significantly, supporting a one-year price target of $306.75 and a Strong Buy recommendation. The new cloud system will enhance productivity, providing better returns for shareholders.
EFX stock is benefiting from the services it offers to its large number of clients and its wide range of products, helping the company stay ahead of its competitors.
Equifax and Mastercard have teamed up to offer fraud management tools to businesses in Latin America, but not in Brazil. This partnership will allow Mastercard's business clients in the region, such as banks and merchants, to access Equifax's Kount Payment Fraud solution. The announcement was made in a press release on Thursday, December 5.
Newcomers to Canada and those new to credit continue to face difficulties with affordability. However, people with mortgages are beginning to experience some improvement.
EFX is using acquisitions to grow its global presence and help its customers meet their hiring and employment requirements.
ATLANTA, Nov. 11, 2024 /PRNewswire/ -- Equifax ® (NYSE: EFX) is set to take part in various investor conferences this November. The CEO, Mark W. Begor, will be present at the J.P.
ATLANTA, Nov. 7, 2024 /PRNewswire/ -- Equifax ® (NYSE: EFX) has announced that Mark W. Begor will remain as Chief Executive Officer (CEO) after his current employment contract ends in 2025.
FAQ
- What is the primary business of Equifax?
- What is the ticker symbol for Equifax?
- Does Equifax pay dividends?
- What sector is Equifax in?
- What industry is Equifax in?
- What country is Equifax based in?
- When did Equifax go public?
- Is Equifax in the S&P 500?
- Is Equifax in the NASDAQ 100?
- Is Equifax in the Dow Jones?
- When was Equifax's last earnings report?
- When does Equifax report earnings?
- Should I buy Equifax stock now?